- Home
- MDGL vs ENIC Comparison
MDGL vs ENIC Comparison
Compare MDGL & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- ENIC
- Stock Information
- Founded
- MDGL 2011
- ENIC 2016
- Country
- MDGL United States
- ENIC Chile
- Employees
- MDGL N/A
- ENIC N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- ENIC Electric Utilities: Central
- Sector
- MDGL Health Care
- ENIC Utilities
- Exchange
- MDGL Nasdaq
- ENIC Nasdaq
- Market Cap
- MDGL 6.1B
- ENIC 5.1B
- IPO Year
- MDGL N/A
- ENIC N/A
- Fundamental
- Price
- MDGL $424.95
- ENIC $3.83
- Analyst Decision
- MDGL Strong Buy
- ENIC Hold
- Analyst Count
- MDGL 10
- ENIC 2
- Target Price
- MDGL $474.67
- ENIC $3.90
- AVG Volume (30 Days)
- MDGL 383.6K
- ENIC 518.6K
- Earning Date
- MDGL 10-30-2025
- ENIC 10-28-2025
- Dividend Yield
- MDGL N/A
- ENIC 4.98%
- EPS Growth
- MDGL N/A
- ENIC N/A
- EPS
- MDGL N/A
- ENIC 0.00
- Revenue
- MDGL $515,547,000.00
- ENIC $4,040,237,917.00
- Revenue This Year
- MDGL $394.12
- ENIC $111,648.61
- Revenue Next Year
- MDGL $57.74
- ENIC N/A
- P/E Ratio
- MDGL N/A
- ENIC $38.38
- Revenue Growth
- MDGL 3421.98
- ENIC N/A
- 52 Week Low
- MDGL $200.63
- ENIC $2.59
- 52 Week High
- MDGL $457.16
- ENIC $4.05
- Technical
- Relative Strength Index (RSI)
- MDGL 58.68
- ENIC 72.93
- Support Level
- MDGL $425.00
- ENIC $3.59
- Resistance Level
- MDGL $440.90
- ENIC $3.71
- Average True Range (ATR)
- MDGL 14.17
- ENIC 0.09
- MACD
- MDGL -4.03
- ENIC 0.03
- Stochastic Oscillator
- MDGL 28.61
- ENIC 95.56
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About ENIC Enel Chile S.A. (Each representing 50 shares of)
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.